Literature DB >> 27521345

Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.

Terri N Iwata1, Julita A Ramírez1, Mark Tsang1, Heon Park1, Daciana H Margineantu2, David M Hockenbery2, Brian M Iritani3.   

Abstract

Mechanistic target of rapamycin (mTOR) is a serine-threonine kinase that coordinates nutrient and growth factor availability with cellular growth, division, and differentiation. Studies examining the roles of mTOR signaling in immune function revealed critical roles for mTOR in regulating T cell differentiation and function. However, few studies have investigated the roles of mTOR in early B cell development. In this study, we found that mTOR is highly activated during the pro- and pre-B stages of mouse B cell development. Conditional disruption of the mTOR coactivating protein Raptor in developing mouse B cells resulted in a developmental block at the pre-B cell stage, with a corresponding lack of peripheral B cells and loss of Ag-specific Ab production. Pre-B cell survival and proliferation were significantly reduced in Raptor-deficient mice. Forced expression of a transgenic BCR or a BclxL transgene on Raptor-deficient B cells failed to rescue B cell development, suggesting that pre-BCR signaling and B cell survival are impaired in a BclxL-independent manner. Raptor-deficient pre-B cells exhibited significant decreases in oxidative phosphorylation and glycolysis, indicating that loss of mTOR signaling in B cells significantly impairs cellular metabolic capacity. Treatment of mice with rapamycin, an allosteric inhibitor of mTOR, recapitulated the early B cell developmental block. Collectively, our data reveal a previously uncharacterized role for mTOR signaling in early B cell development, survival, and metabolism.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27521345      PMCID: PMC5009877          DOI: 10.4049/jimmunol.1600492

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.

Authors:  Seth A Wander; Bryan T Hennessy; Joyce M Slingerland
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

Review 2.  mTOR and metabolic regulation of conventional and regulatory T cells.

Authors:  Chaohong Liu; Nicole M Chapman; Peer W F Karmaus; Hu Zeng; Hongbo Chi
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

3.  mTORC1 is essential for leukemia propagation but not stem cell self-renewal.

Authors:  Takayuki Hoshii; Yuko Tadokoro; Kazuhito Naka; Takako Ooshio; Teruyuki Muraguchi; Naoyuki Sugiyama; Tomoyoshi Soga; Kimi Araki; Ken-Ichi Yamamura; Atsushi Hirao
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

4.  Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription.

Authors:  M S Schlissel; D Baltimore
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

5.  Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development.

Authors:  Heon Park; Karen Staehling; Mark Tsang; Mark W Appleby; Mary E Brunkow; Daciana Margineantu; David M Hockenbery; Tania Habib; H Denny Liggitt; George Carlson; Brian M Iritani
Journal:  Immunity       Date:  2012-05-17       Impact factor: 31.745

6.  Control of cell growth by c-Myc in the absence of cell division.

Authors:  M Schuhmacher; M S Staege; A Pajic; A Polack; U H Weidle; G W Bornkamm; D Eick; F Kohlhuber
Journal:  Curr Biol       Date:  1999-11-04       Impact factor: 10.834

7.  T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming.

Authors:  Kai Yang; Sharad Shrestha; Hu Zeng; Peer W F Karmaus; Geoffrey Neale; Peter Vogel; David A Guertin; Richard F Lamb; Hongbo Chi
Journal:  Immunity       Date:  2013-12-05       Impact factor: 31.745

8.  Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow.

Authors:  Hidefumi Kojima; Ayano Kobayashi; Daisuke Sakurai; Yumiko Kanno; Hidenori Hase; Riichi Takahashi; Yoshikazu Totsuka; Gregg L Semenza; Michail V Sitkovsky; Tetsuji Kobata
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

9.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  Myc stimulates B lymphocyte differentiation and amplifies calcium signaling.

Authors:  Tania Habib; Heon Park; Mark Tsang; Ignacio Moreno de Alborán; Andrea Nicks; Leslie Wilson; Paul S Knoepfler; Sarah Andrews; David J Rawlings; Robert N Eisenman; Brian M Iritani
Journal:  J Cell Biol       Date:  2007-11-12       Impact factor: 10.539

View more
  33 in total

1.  mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.

Authors:  Naresh Kumar Meena; Shakti Prasad Pattanayak; Yael Ben-Nun; Sandrine Benhamron; Saran Kumar; Emmanuelle Merquiol; Nadine Hövelmeyer; Galia Blum; Boaz Tirosh
Journal:  Immunology       Date:  2018-09-16       Impact factor: 7.397

Review 2.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

3.  B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity.

Authors:  Ariel L Raybuck; Sung Hoon Cho; Jingxin Li; Meredith C Rogers; Keunwook Lee; Christopher L Williams; Mark Shlomchik; James W Thomas; Jin Chen; John V Williams; Mark R Boothby
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

Review 4.  Control of B lymphocyte development and functions by the mTOR signaling pathways.

Authors:  Terri N Iwata; Julita A Ramírez-Komo; Heon Park; Brian M Iritani
Journal:  Cytokine Growth Factor Rev       Date:  2017-05-22       Impact factor: 7.638

5.  Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction.

Authors:  Bingshou Li; Zhirong Li; Pengcheng Wang; Qizhao Huang; Lifan Xu; Ran He; Lilin Ye; Qiang Bai
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 6.  Fine tuning of immunometabolism for the treatment of rheumatic diseases.

Authors:  Jillian P Rhoads; Amy S Major; Jeffrey C Rathmell
Journal:  Nat Rev Rheumatol       Date:  2017-04-06       Impact factor: 20.543

7.  PI3K Isoforms in B Cells.

Authors:  Elissa K Deenick; Julia Bier; Anthony Lau
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 8.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

9.  Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3.

Authors:  Julita A Ramírez; Terri Iwata; Heon Park; Mark Tsang; Janella Kang; Katy Cui; Winnie Kwong; Richard G James; Masaya Baba; Laura S Schmidt; Brian M Iritani
Journal:  J Immunol       Date:  2019-11-01       Impact factor: 5.422

10.  mTORC1 as a cell-intrinsic rheostat that shapes development, preimmune repertoire, and function of B lymphocytes.

Authors:  Ariel L Raybuck; Keunwook Lee; Sung Hoon Cho; Jingxin Li; James W Thomas; Mark R Boothby
Journal:  FASEB J       Date:  2019-09-18       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.